244 related articles for article (PubMed ID: 33836578)
1. Expansions of adaptive-like NK cells with a tissue-resident phenotype in human lung and blood.
Brownlie D; Scharenberg M; Mold JE; Hård J; Kekäläinen E; Buggert M; Nguyen S; Wilson JN; Al-Ameri M; Ljunggren HG; Marquardt N; Michaëlsson J
Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836578
[TBL] [Abstract][Full Text] [Related]
2. Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69
Marquardt N; Kekäläinen E; Chen P; Kvedaraite E; Wilson JN; Ivarsson MA; Mjösberg J; Berglin L; Säfholm J; Manson ML; Adner M; Al-Ameri M; Bergman P; Orre AC; Svensson M; Dahlén B; Dahlén SE; Ljunggren HG; Michaëlsson J
J Allergy Clin Immunol; 2017 Apr; 139(4):1321-1330.e4. PubMed ID: 27670241
[TBL] [Abstract][Full Text] [Related]
3. Influenza A Virus Infection Induces Hyperresponsiveness in Human Lung Tissue-Resident and Peripheral Blood NK Cells.
Scharenberg M; Vangeti S; Kekäläinen E; Bergman P; Al-Ameri M; Johansson N; Sondén K; Falck-Jones S; Färnert A; Ljunggren HG; Michaëlsson J; Smed-Sörensen A; Marquardt N
Front Immunol; 2019; 10():1116. PubMed ID: 31156653
[TBL] [Abstract][Full Text] [Related]
4. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.
Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J
J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8
Brownlie D; von Kries A; Valenzano G; Wild N; Yilmaz E; Säfholm J; Al-Ameri M; Alici E; Ljunggren HG; Schliemann I; Aricak O; Haglund de Flon F; Michaëlsson J; Marquardt N
Oncoimmunology; 2023; 12(1):2233402. PubMed ID: 37448786
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells.
Marquardt N; Béziat V; Nyström S; Hengst J; Ivarsson MA; Kekäläinen E; Johansson H; Mjösberg J; Westgren M; Lankisch TO; Wedemeyer H; Ellis EC; Ljunggren HG; Michaëlsson J; Björkström NK
J Immunol; 2015 Mar; 194(6):2467-71. PubMed ID: 25672754
[TBL] [Abstract][Full Text] [Related]
7. Late Development of FcεRγ
Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
Front Immunol; 2018; 9():1050. PubMed ID: 29868012
[TBL] [Abstract][Full Text] [Related]
8. CD3(-)CD16(-)CD56(bright) immunoregulatory NK cells are increased in the tumor microenvironment and inversely correlate with advanced stages in patients with papillary thyroid cancer.
Gogali F; Paterakis G; Rassidakis GZ; Liakou CI; Liapi C
Thyroid; 2013 Dec; 23(12):1561-8. PubMed ID: 23721357
[TBL] [Abstract][Full Text] [Related]
9. Role of chemokines in the biology of natural killer cells.
Maghazachi AA
Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317
[TBL] [Abstract][Full Text] [Related]
10. IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells.
Hydes T; Noll A; Salinas-Riester G; Abuhilal M; Armstrong T; Hamady Z; Primrose J; Takhar A; Walter L; Khakoo SI
Immun Inflamm Dis; 2018 Mar; 6(1):34-46. PubMed ID: 28952190
[TBL] [Abstract][Full Text] [Related]
11. NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes.
Gomez-Muñoz L; Perna-Barrull D; Villalba A; Rodriguez-Fernandez S; Ampudia RM; Teniente-Serra A; Vazquez F; Murillo M; Perez J; Corripio R; Bel J; Vives-Pi M
Front Immunol; 2020; 11():611522. PubMed ID: 33569058
[TBL] [Abstract][Full Text] [Related]
12. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver.
Harmon C; Robinson MW; Fahey R; Whelan S; Houlihan DD; Geoghegan J; O'Farrelly C
Eur J Immunol; 2016 Sep; 46(9):2111-20. PubMed ID: 27485474
[TBL] [Abstract][Full Text] [Related]
13. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling.
Hanna J; Bechtel P; Zhai Y; Youssef F; McLachlan K; Mandelboim O
J Immunol; 2004 Dec; 173(11):6547-63. PubMed ID: 15557145
[TBL] [Abstract][Full Text] [Related]
14. Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations.
Melsen JE; Lugthart G; Lankester AC; Schilham MW
Front Immunol; 2016; 7():262. PubMed ID: 27446091
[TBL] [Abstract][Full Text] [Related]
15. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
[TBL] [Abstract][Full Text] [Related]
16. Antiviral Responses of Tissue-resident CD49a
Cooper GE; Mayall J; Donovan C; Haw TJ; Budden KF; Hansbro NG; Blomme EE; Maes T; Kong CW; Horvat JC; Khakoo SI; Wilkinson TMA; Hansbro PM; Staples KJ
Am J Respir Crit Care Med; 2023 Mar; 207(5):553-565. PubMed ID: 36170617
[No Abstract] [Full Text] [Related]
17. Unique transcriptional and protein-expression signature in human lung tissue-resident NK cells.
Marquardt N; Kekäläinen E; Chen P; Lourda M; Wilson JN; Scharenberg M; Bergman P; Al-Ameri M; Hård J; Mold JE; Ljunggren HG; Michaëlsson J
Nat Commun; 2019 Aug; 10(1):3841. PubMed ID: 31451696
[TBL] [Abstract][Full Text] [Related]
18. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
19. Timing of Antiretroviral Therapy Initiation Determines Rectal Natural Killer Cell Populations.
Utay NS; Vigil KJ; Somasunderam A; Aulicino PC; Smulevitz B; Chiadika S; Wolf DS; Kimata JT; Arduino RC
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):314-323. PubMed ID: 31838858
[TBL] [Abstract][Full Text] [Related]
20. CD16- CD56+ natural killer cells after bone marrow transplantation.
Jacobs R; Stoll M; Stratmann G; Leo R; Link H; Schmidt RE
Blood; 1992 Jun; 79(12):3239-44. PubMed ID: 1375847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
